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The  role  of the  antigen-presenting cell  in  the  generation  of the  T  helper 
lymphocyte-mediated immune response has been the subject of intensive inves- 
tigation. To date it has been well established that accessory cells take up, sequester 
in intracellular compartments, and re-express antigen at the cell surface mem- 
brane  in an  energy-requiring,  dynamic process that  requires  cell viability (re- 
viewed in references 1-3).  Various investigators have shown that T  cells recog- 
nize antigen in association with I-A and I-E molecules present on the surface of 
the accessory cell (4, 5) and that different antigen determinants may be recog- 
nized in association with distinct Ia epitopes (6-9). 
There  is  considerable circumstantial  evidence that for most soluble protein 
antigens the re-expressed surface antigen that is recognized by T  cells is not in 
native  form.  Several  studies  have  shown  that  T  cells  recognize  chemically 
denatured forms of antigen just as well as native, globular protein (10,  11) and 
that small peptide antigen fragments can be as effective as the whole protein in 
generating T  cell responses (12-14).  Furthermore,  kinetic studies have shown 
an approximately 1-h delay between initial antigen binding to accessory cells and 
effective antigen presentation to T  cells (15-17). Agents that raise lysosomal pH, 
such as ammonia and chloroquine, inhibit the development of effective antigen 
presentation when given immediately after antigen binding to accessory cells but 
not at later times (18). 
All of these findings have led to the concept of "antigen processing", which 
based on the information referred to above, has been interpreted to involve the 
obligatory partial degradation of internalized antigen by accessory cells followed 
by the re-expression on the surface membrane of antigenic fragments in a form 
that can be seen in association with Ia molecules by T  cells. 
There have been several obstacles in the way of defining antigen processing 
more  precisely.  First  it  has  been  impossible  to  distinguish  which part  of the 
antigen degradation seen in accessory cells is essential for antigen presentation 
and which part is not. Secondly, it has been difficult to determine whether or 
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not antigen processing involves other modifications to the antigen in addition to 
degradation. 
In this paper we report an experimental technique that has allowed us to make 
headway  against  both  of these  problems.  We  used  the  Ia  ÷  BALB/c  B  cell 
lymphoma, A20-2J,  as an antigen-presenting accessory cell and the stimulation 
of interleukin-2 (I L-2)  1 production by a set of chicken ovalbumin (cOVA)-specific, 
Ia-restricted  T  cell  hybridomas  as  the  means  of  detecting  immunologically 
relevant antigen. Under these conditions viable A20-2J presented native, dena- 
tured, and enzymatically or  chemically derived peptides  equally well to  many 
hybridomas. Most critically however, glutaraldehyde-fixed A20-2J cells presented 
peptides,  but neither native  nor denatured intact antigen.  We interpret  these 
results  to  mean  that  for  this  antigen  and  this  set  of T  cells  partial  antigen 
degradation is both a necessary and sufficient condition for antigen presentation. 
Materials and Methods 
Mice.  The BALB/c By, B10.D2nSn, D2.GD, and D1.LP mice used to characterize 
the T  hybridomas used in these experiments were originally purchased from the Jackson 
Laboratories, Bar Harbor, ME or were bred in our own facilities. 
Antigens.  Chicken (c) and turkey (t) ovalbumins (OVA) were purchased from the Sigma 
Chemical Co., St. Louis, MO. Red jungle fowl (jt') OVA, reeves pheasant (ph) OVA, and 
chiloe widgeon (w) OVA  were prepared  from eggs obtained courtesy of Ed Schmitt, 
curator, the Denver Zoo, Denver, CO by ammonium sulfate precipitation from egg white 
and  carboxy-methyl agarose  chromatography (19,  20).  Bobwhite quail  (q)  OVA  was 
prepared  in a  similar manner from eggs obtained from the GQF Manufacturing Co., 
Savannah, GA. Polyacrylamide  gel electrophoresis showed that all these OVA preparations 
contained a major band that migrated with a molecular weight of ~43,000 daltons that 
co-migrated with the commercially obtained cOVA and tOVA. 
Urea-denatured cOVA was prepared as previously described (11). After denaturation 
with 8  M urea, reduction with 0.2  M  2-mercaptoethanol, and alkylation with sodium 
iodoacetate, the preparation was sequentially dialyzed against distilled water, buffered 
saline,  and finally balanced salts solution. Sephadex G-75 chromatography was used to 
separate the opalescent, partially aggregated denatured cOVA from contaminating low 
molecular weight fragments. 
Enzyme digestions and chemical degradation of denatured chicken OVA were carried 
out as described (21). Trypsin digestion was performed by addition of 1% wt/wt trypsin 
(TPCK-treated, Worthington Biochemical Co., Freehold, N  J) to 200 mg protein in 0.1 M 
NH4HCO3,  pH  8.2. After 4 h at 37°C, another identical aliquot of enzyme was added 
and the reaction was allowed to proceed overnight before lyophilization. Modification of 
lysine residues with citraconic anhydride (Eastman Kodak Co., Rochester, NY) before 
trypsin digestion of denatured chicken OVA (therefore allowing cleavage only at arginine 
residues) was performed as previously described (22). After trypsin digestion was complete, 
the lysine residues were unblocked by treatment with 0.04 M pyridine-acetate buffer, pH 
3.5.  Chymotrypsin digestion was  effected by the  addition of 2%  alpha-chymotrypsin 
(Worthington Biochemical Co.) to 200 mg protein. After 4 h at 37°C the reaction was 
stopped by the addition of 160  ~1  1 mM TPCK and the preparation lyophilized. For 
cyanogen bromide (CNBr) degradation, 168 mg protein was taken up in 70% formic acid 
and 1.68 g CNBr (Sigma Chemical Co.) added. Overnight incubation in the dark at room 
temperature was halted by lyophilization. 
t Abbreviations  used  in  this  paper:  c, chicken; cOVA, chicken ovalbumin; H-2, histocompatibility 
gene  complex  of the  mouse;  Ia,  I-region associated antigens;  I-A and  I-E/C,  the  A  and  E/C 
subregions, respectively, of the I-region of the mouse H-2; IL-2, interleukin-2; jf, red jungle fowl; 
MHC, major histocompatibility complex; OVA, ovalbumin; ph, pheasant; q, bobwhite quail; SDS, 
sodium dodecyl sulfate; t, turkey, w, chiloe widgeon. SHIMONKEVITZ  ET  AL.  305 
T Lymphocyte Hybridomas.  The cloned, antigen-specific, H-2-restricted T  lymphocyte 
hybridomas used in this study were produced and characterized in a similar manner to 
that described previously (23). Briefly, 6-8-wk old normal BALB/c By mice were injected 
with  100 #g cOVA in complete Freund's adjuvant at the base of the tail.  7 d  later the 
draining lymph nodes were excised and the cells  cultured for 5 d  in the presence of 
antigen in modified Clicks medium. After a subsequent 3-d expansion in IL-2-containing 
medium, the antigen-reactive T  cell blasts  were fused to an azaguanine-resistant variant 
of the AKR thymoma BW5147 with polyethylene glycol. Resultant hybrids were selected 
for in hypoxanthine/aminopterin/thymidine-containing media and were screened for the 
production of IL-2 when cultured with cOVA in the presence of A20-2J B lymphoma 
cells. A subset of these initial hybridomas were selected for cloning based on their unique 
patterns of cross-reactivity with a series of heterologous OVA's and their alloreactivity 
against cells bearing H-2 types other than d. Cloning was performed at limiting dilution 
under conditions in which the selected clones had less than a 2.4% chance of arising from 
more than one cell. In general, one clone of each hybrid was selected for use and its I 
subregion restriction determined by mapping antigen responsiveness on BALB/c By (I- 
A d, I-Ed), BI0.D2 (I-A  d, I-Ed), D2.GD (I-Ad,I-Ea~nt),  and D1.LP (I-Ab,I-E  abe"') irradiated 
spleen  cells.  This  MHC-restriction  was  confirmed  by  assaying  inhibition  of antigen 
d  d  d  d  presentation by the I-A , I-E -expressing A20-2J cells using the anti-I-A  (but not I-E )- 
specific MK-D6 and the anti-I-A  d, I-Ed-specific M5/114 monoclonal antibodies. In addition 
the alloreactivity of each hybrid was tested with spleen cells from a set of H-2 congenic 
and  recombinant  mice  covering the  k,  b,  s,  q,  and  f  haplotypes.  The  antigenic  fine 
specificities, I subregion restrictions, and alloreactivities of the T  hybridomas are shown 
in Table I. In addition to the antigens displayed in Table I  these T  hybridomas were 
negative for IL-2 production when assayed for reactivity on A20-2J presenting cells to 
duck OVA, goose OVA, chicken conalbumin, purified protein derivative of tuberculin, 
keyhole limpet hemocyanin, human gamma globulin, and the synthetic polymer poly-L- 
(Tyr,Glu)-poly t),L-Ala--poly  L-Lys (data  not  shown).  Also,  with the exception of DO- 
11.10,  none of these hybridomas reacted to cOVA or any of the other OVA's  when 
presented by presenting cells of other than H-2  d type. 
Antigen-presenting Cells.  The I-A  d, I-Ed-positive A20-2J (known previously as L10A.2J) 
B lymphoma line that has previously been shown to present antigen in an MHC-restricted 
fashion to T  cells (24) was used in these experiments. For use in antigen presentation, 
A20-2J cells were centrifuged from bulk culture and resuspended to appropriate concen- 
trations for addition to micro-culture wells. Antigen-pulsed A20-2J were cultured in the 
presence of 1 mg/ml OVA for 2 h at 37°C, washed twice with balanced salts solution, 
and added to micro-culture wells. Our studies with cOVA and previous studies with other 
antigens (25,  26) showed that at  least 60  rain  was  required for processing of protein 
antigens  by A20-2J.  For fixation, cells were washed twice with balanced salts  solution 
(after antigen pulsing, if desired) and 5 ×  10  ~ cells per ml in balanced salts solution were 
fixed by the addition of glutaraldehyde (Sigma Chemical Co.) to a final concentration of 
0.05%. After 30 s at room temperature the fixation was stopped by the addition of an 
equal volume of 0.2 M lysine (Sigma Chemical Co.) in balanced salts solution, pH  7.4. 
The cells  were then centrifuged and washed once before use.  Cells  fixed under these 
conditions could  be  stored  at  4°C  for  up  to  3  wk  without  impairing  their antigen- 
presenting capabilities. 
Antigen  Stimulation  Cultures  and Assay for IL-2 Production.  Assay  for antigen-specific 
stimulation of IL-2 production by T  hybridomas was performed as previously described 
(23) in  96-well  tissue culture-treated micro-culture plates (Flow Laboratories, McLean, 
VA) using I  ×  10  ~ A20-2J B lymphoma presenting cells,  1 ×  10  ~ T  hybridoma cells and 
(when desired)  1 mg/ml antigen in 0.3 ml complete medium. Cultures were incubated 
for 24 h at 37°C whereupon the presence of IL-2 in the culture supernates was assayed 
by using the IL-2-dependent HT-2 cell line. IL-2 titers are expressed in U/ml. 
Amino Acid Incorporation by Glutaraldehyde-fixed A20-2J Cells.  Indicated number of A20- 
2J, freshly 0.05% glutaraldehyde-fixed A20-2J, and A20-2J cells that had been fixed 5 d 
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0.2 ml of medium containing [SH]leucine (600 #M, 33 pCi/pmole, New England Nuclear, 
Boston, MA).  Cultures were then harvested onto glass fiber paper,  washed, fixed  with 
10%  trichloroacetic acid and absolute methanol and [3H]leucine incorporation enumer- 
ated on a Beckman LS-2800 scintillation counter. 
Catabolism of l~5I-Labeled cOVA.  Denatured cOVA was labeled with I~I by the Chior- 
amine T  method (26). In order to assess the ability of A20-2J cells to catabolize denatured 
cOVA after fixation,  5  ×  10 ~ fixed or unfixed A20-2J  cells were incubated for 24  h at 
37°C  in  1.0  ml of medium containing  1 mg ~I-cOVA  (~  2  gCi/mg).  The cells were 
then collected and washed once with balanced salt solution.  The  ~SI-cOVA  remaining 
associated with the cells was examined by dissolving the cell pellet in 1.5% sodium dodecyl 
sulfate (SDS) containing 2-mercaptoethanol and analyzing a portion of the lysate using 
SDS-polyacrylamide  gel  electrophoresis  according  to  the  method of Laemmli  (27).  A 
12.5%  gel was used. The  t25I-labeled  peptides were visualized using Kodak XAR-S film 
exposed at -70°C. 
Results 
Antigenic Fine Spec~cities of the T Hybridomas.  The T  cell hybridomas used in 
these experiments were prepared from three separate hybridizations of BALB/ 
c  anti-OVA  T  cell  blasts  to  BW5147  thymoma  cells.  T  hybridomas  prepared 
under identical conditions have already been characterized (23) and, therefore, 
the general properties of these cells will not be discussed. As can be seen in Table 
I, when assayed  by their ability  to be stimulated  to produce  IL-2,  each of the 
selected cOVA-specific  hybrids  had a  unique  specificity defined by the combi- 
nation of its I-region restriction specificity, its cross-reactivity pattern with a set 
of heterologous OVA's, and its pattern of alloreactivity on non-H-2 a presenting 
cells.  In constructing this set of cOVA-specific hybridomas,  each with a unique 
receptor,  we hoped  to cover as  many of the various  ways as possible  in which 
BALB/c T  cells could recognize cOVA in association with either the I-A  a or I- 
E  d molecule.  In  retrospect,  based  on  the  evidence  presented  below,  it  would 
appear that this set of hybridomas define a number of different antigenic regions 
on the cOVA molecule, although some members of the set appear to recognize 
TABLE  I 
Cloned BALB / c-derived, cOVA-spec~c, U-restricted T Cell Hybridomas Used in These Studies 
IL-Production  (U/ml)  in response  to A20-2J  cells presenting  these  Alloreactivity 
antigens  1-sub region 
Hybridoma  restriction 
No an-  IL-2  Speci- 
cOVA  jfOVA  phOVA  tOVA  qOVA  wOVA  tigen  ficity 
U/ml 
3DO-26.1  640  160  320  320  --  --  --  I-E  d  --  none 
3DO-36.6.1  80  320  --  640  80  --  --  I-E  d  --  none 
4DO-63.10  320  --  640  320  --  --  --  I-E  d  --  none 
3DO-54.8  640  320  --  --  160  --  --  FA d  80  I-A t~ 
10  1-A  k 
3DO-54.6  640  160  .....  I-A d  --  none 
DO-I  1.10  640  320  .....  I-A d~b  20  I-A  b 
3DO-18.3  640  640  320  --  320  --  --  I-A d  --  none 
3DO-46.4  320  160  320  ....  FA d  --  none 
3DO-20.10  640  ......  FA d  --  none 
4DO-I  1.7  640  --  --  640  --  320  --  I-A d  --  none 
Antigen  stimulation  cultures  and IL-2  assay performed  as described  in the  Materials and Methods.  Data presented  is averaged  from 
numerous assays over a  several  week period.  Variance of IL-2 responses  are ±  one dilution except  for negative  responses  which were 
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the same general  region  of cOVA,  with  fine specificity differences defined by 
their patterns of cross-reactivity. 
There  are  several  points  worth  noting  about  the  reactivity  patterns  of the 
hybridomas. 3DO-36.6.1, although produced from cOVA-immune animals, con- 
sistently responded poorly to cOVA but strongly to tOVA. 3DO-54.6 and 3DO- 
54.8  are  clones  that  were  derived  from  the  same  primary  hybridoma  well, 
although  they clearly had  different  fine specificity patterns.  It is possible that 
these were two independent hybrids which happened to grow in the same well, 
or that these were derived from two progeny of the same hybrid that differ in 
specificity because of a receptor mutation or differ in antigen sensitivity because 
of differences in  receptor density,  for example.  We cannot distinguish  among 
these possibilities at present,  so both hybrids were included  in the study.  DO- 
11.10 had a very unusual specificity in that its very weak response to I-A  b as an 
alloantigen was dramatically improved by the addition of cOVA. 
Effect of Fixation on Antigen Presentation.  In previous studies using a  number 
of I-region  restricted  T  cell  hybridomas  specific for protein  antigens,  we and 
others (17, 26) reported evidence for the importance of antigen processing by 
showing that antigen-presenting cells preincubated for several hours with antigen 
could be fixed without impairing  their ability to present antigen.  On the other 
hand, antigen.added after fixation was not presented. Table II shows that cOVA 
presentation  by A20-2J to a  number of the hybrids listed in  Table  I  followed 
similar rules.  These cOVA-specific hybrids responded to cOVA-pulsed A20-2J 
cells, although  not as well as to cOVA continuously present at high  levels with 
A20-2J cells. Glutaraldehyde fixation of the previously pulsed A20-2J cells had 
no effect on their ability to present cOVA. Most importantly,  A20-2J cells that 
were fixed without pulsing with cOVA were unable to present cOVA even when 
tested with high concentrations of continuously present cOVA. 
These  findings  reconfirmed  the  reports  by  us  and  others  supporting  the 
conclusion  that  protein  antigens  such as cOVA are not recognized in a  native 
form  by  I-region  restricted  T  cells.  Rather  they  suggest  that  the  antigen- 
TABLE  II 
Response of T Hybridomas to Antigen-pulsed and O. 05% Glutaraldehyde~xed A20-2J Presenting 
Cells 
U/ml IL-2 production in response to: 
Glutaraldehyde- 
Glutaraldehyde-  pre-fixed A20-  Hybridoma  A20-2J plus 1 mg/  cOVA-pulsed  fixed cOVA  2J + 
ml added cOVA  A20-2J  pulsed A20-2J  1 mg/ml added 
cOVA 
3DO-18.3  1,280  160  160  0 
3DO-54.8  1,280  160  160  0 
3DO-54.6  640  20  20  0 
DO-I 1.10  640  80  80  0 
4DO-11.7  1,280  40  40  0 
Conditions of assay, antigen pulsing and glutaraldehyde fixation of presenter cells  as described in the 
Materials and Methods. Data presented is averaged from numerous assays. Variance  of IL-2 responses 
are +_- one twofold  dilution except for negative responses, which were never positive. 308  CELL-FREE  ANTIGEN  PROCESSING 
presenting cells must alter or process the antigen to a form that can be recognized. 
Ability of Glutaraldehyde-fixed A20-2J Cells to Present Enzymatically and Chemically 
Generated OVA Peptides to the T Hybridomas.  We then designed a  set of experi- 
ments to attempt to define more precisely what the essential antigen processing 
steps might be. Some of the possibilities we wished to distinguish were (a) that 
processing simply involved the denaturation of the protein, (b) that processing 
required the proteolytic cleavage of the protein into smaller peptides, and (c) 
that processing required other intracellular modifications to  the protein,  e.g. 
covalent coupling to membrane components during membrane biogenesis. 
To test these possibilities we examined the ability of A20-2J cells before and 
after fixation to present exogenously added native cOVA, denatured cOVA, and 
cOVA peptides prepared by either enzymatic or CNBr cleavage of denatured 
cOVA. We reasoned that if denaturation was the essential feature of processing 
then  this  inability  of fixed  A20-2J  cells  to  present  native  cOVA  should  be 
overcome by denaturation of the antigen. Similarly, if partial degradation was 
the critical step in processing then at least for some hybrids we should be able to 
restore the presenting ability of A20-2J cells by the right set of cleavages of the 
cOVA molecule in vitro. Finally, if some other essential intracellular event was 
required  for processing then  none  of our  extracellular manipulations should 
restore the presenting ability of the fixed A20-2J cells. 
The results of these experiments are summarized in Table III. The left-hand 
side of Table III shows the production of IL-2 by the T  hybridomas in response 
to cOVA, denatured cOVA, the tryptic and chymotrypic peptides, the tryptic 
peptides of citraconylated cOVA, and the cyanogen bromide-generated peptides 
of cOVA  as  presented  by  nonfixed  A20-2J  cells.  As  predicted  by  previous 
experience with protein antigens, all but two of the hybrids responded to both 
the native and denatured form of cOVA indicating that in general the T  cells 
do  not recognize conformational determinants found in  the native  molecule. 
Two hybrids failed to respond to denatured cOVA. In the case of 3DO-36.6.1, 
as discussed below,  this  failure to  respond appeared  to  be related to antigen 
processing  rather  than  to  the  destruction  of the  recognized determinant by 
denaturation.  On  the  other  hand,  the  hybridoma  4DO-11.7  was  apparently 
reactive  to  a  determinant  on  native  cOVA  that  was  destroyed  by  the  urea 
denaturation or by the alkylation of cysteine residues. 
Also, most of the hybridomas could be shown to react with at least one of the 
peptide preparations  to  a  similar extent as  to  the native or  denatured intact 
molecule, although, as might be expected, different hybridomas showed different 
patterns of reactivity to cOVA fragmented by each of the methods. 
The right half of Table III shows the results of testing the ability of previously 
fixed A20-2J cells to present the various cOVA preparations. As shown in Table 
II,  these fixed cells could not present native cOVA to any of the hybridomas 
demonstrating  the  need  for  some  active,  metabolic  processing  event  before 
presentation. Denaturation of the cOVA did not restore its ability to be presented 
by the fixed A20-2J cells, indicating that denaturation alone did not account for 
processing. Remarkably, in 7 out of 10 hybridomas, the antigen-presenting ability 
of the  fixed  cells  was  restored  by  at  least  one  of the  cOVA  fragmentation 
methods. SHIMONKEVITZ  ET  AL.  309 
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The presence of both antigen (cOVA peptides) and fixed A20-2J presenters 
are required for recognition. The anti-I  subregion-specific MK-D6  (anti-I-A  a) 
and M5/114  (anti-I-A, E  a) monoclonal antibodies inhibit these responses in the 
same manner as with the intact antigens presented by viable A20-2J cells (data 
not shown). We consider this evidence that the OVA-specific H-2-restricted T 
hybridomas are recognizing the OVA peptides on  the fixed presenters in  an 
identical fashion as they recognize native antigen presented by viable A20-2J or 
macrophage presenters.  Indeed, when the T  hybridomas 3DO-18.3  and 3DO- 
54.8  were assayed for specific secretion of IL-2 in response to cOVA peptides 
on 0.1% glutaraldehyde-fixed BALB/c resident peritoneal cells, the same pattern 
of reactivity was observed as that seen with fixed A20-2J presenters (data not 
shown).  The  phenomenon  is  not  unique,  therefore,  to  B  cell  or  tumor  cell 
presenters as it can be demonstrated with fixed normal macrophages. 
These results lead us to the major conclusion of this study: that for this set of 
cOVA-specific T  cell hybridomas, the fragmentation of the cOVA to peptides is 
both necessary and, more importantly, sufficient to explain antigen processing. 
These results argue strongly against an essential role in processing for intracel- 
lular modifications other than antigen degradation. 
There are a  number of other important observations to be made from the 
data in Table III. Hybridoma 4DO-11.7  failed to respond to denatured cOVA 
or any of the cOVA peptide preparations whether presented by fixed or nonfixed 
A20~2J.  As  mentioned above,  the  most  straightforward interpretation of this 
result is that the denaturation of cOVA permanently destroyed the determinant 
recognized by the hybridoma, either because the determinant is conformational 
or fails to survive the alkylation of the cOVA sulfhydryi groups. 
The response pattern of 3DO-36.6.1  was particularly unexpected. As shown 
in  Table  I,  although  this  hybridoma  was  derived  from  a  cOVA-immunized 
mouse, it showed a  poor response to cOVA, but a  strong response to  tOVA. 
This might have indicated a determinant in cOVA with very low affinity for the 
receptor on  3DO-36.6.1  that  was dramatically improved by a  species-specific 
amino acid substitution found in tOVA. The data in Table III, however, suggests 
an alternate explanation. The fact that trypsin treatment of citraconylated cOVA 
restored a strong response by 3DO-36.6.1  to this antigen indicates the presence 
of an equally effective determinant in both cOVA and tOVA. It would appear 
that this determinant can be processed efficiently by A20-2J from tOVA but not 
from cOVA unless helped by the appropriate extracellular enzyme treatment. 
In no case did we observe a response with fixed A20-2J cells that was not also 
evident with unfixed cells. However, there were several examples where cleavage 
with a particular method yielded cOVA peptides that were presented by nonfixed 
but not by fixed A20-2J cells. This was particularly true with CNBr cleavage or 
digestion of the citraconylated cOVA with trypsin. Since these methods could 
be predicted to yield the largest cOVA fragments, it is possible that in some cases 
the degradation of the cOVA was not sufficient to release the relevant peptide. 
In this respect it will be interesting in the future to establish whether combining 
these or other fragmentation methods might reveal the relevant peptide in these 
partially degraded proteins. 
While the data presented in Tables I and III support the conclusion that the SHIMONKEVITZ  ET  AL.  311 
hybrids used in  these studies  each  had a  unique  receptor defined by its  fine 
specificity, the patterns of reactivity seen in  Table  III  suggest that certain of 
these hybrids nevertheless may be responding to the same portion of the cOVA 
molecule. For example, the responses of 3DO-26.1 and 4DO-63.10 to the cOVA 
peptides were strikingly similar,  suggesting a  particular portion of the cOVA 
molecule may be preferentially seen in association with I-E  d. Similarly 3DO-54.6, 
3DO-54.8, and DO-11.10  had similar reactivity patterns with the cOVA frag- 
ments, again suggesting a response to a common region of the cOVA molecule. 
In preliminary experiments fractionating the cOVA tryptic peptides, we have 
strengthened this conclusion with the finding that each of these three hybrids 
apparently recognize the same tryptic peptide. 
Evidence for Fixation of A20-2J.  It  was critical  to  the  interpretation  of our 
results that  the fixation of A20-2J  cells be effective. Others have shown that 
treatment of different cell  lines  with  varying amounts of glutaraldehyde can 
eliminate amino acid or nucleic acid incorporation and antibody plus complement 
or cytotoxic T  cell recognition and lysis (28). Although the data presented here 
is  for 0.05%  glutaraldehyde-fixed A20-2J  cells, presentation of cOVA digests 
occurs in an undiminished fashion, as evidenced by T  cell secretion of IL-2, by 
A20-2J cells prefixed with concentrations of glutaraldehyde up to 0.3% for 30 s 
at room temperature (data not shown). The fact that the glutaraldehyde fixation 
totally eliminated the ability of A20-2J to present nondegraded cOVA certainly 
indicated a  severe diminution of the cells' metabolic capabilities.  However, we 
performed several additional control experiments to assess further the metabolic 
activity of these  cells.  We  determined that  these  fixed  cells  were  unable  to 
proliferate in culture (data not shown). Furthermore, as shown in Table IV, the 
fixation procedure reduced protein synthesis as evidenced by the ability of A20- 
2J to incorporate [SH]leucine into acid insoluble material, to  1% or less of that 
seen in unfixed cells. We haven't determined as yet whether this small residual 
activity reflects actual protein synthesis or simply trapping of a small amount of 
the free [SH]leucine in the acid-precipitated cells. In addition, the stability of the 
fixed cells was tested. Fixed A20-2J cells that had been stored at 4°C for up to 
3 wk were unaffected in their ability to present cOVA peptide fragments to the 
cOVA-specific hybrids (Table V).  We assessed the ability of fixed or unfixed 
A20-2J cells to degrade denatured cOVA. Cells were incubated overnight with 
TABLE  IV 
Inhibition of Protein Synthesis by 0.05%  Glutaraldehyde Fixation 
No. of A20-2J cells 
[SH]Leucine incorporated into TCA precipitable 
material (cpm ×  I0  -s) 
Nonfixed A20-2J 
Freshly glutar-  5-d previously 
aldehyde-fixed  glutaraldehyde- 
A20-2J  fixed A20-2J 
5  ×  105  101  1.4  0.4 
1 x  105  20.7  0.1  0.1 
Assay conditions described in the Materials and Methods. Data shown are 
averaged from duplicate counts of a single experiment from which back- 
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TAnLE  V 
Stability of O. 05% Glutaraldehyde~xed A20-2J Cells 





Freshly fixed A20-2J plus  A20-2J fixed 3 wk earlier plus 
trypsin  CNBr  trypsin  CNBr 
native  native  treated-  treated-  native  cOVA  cOVA  cOVA  treated-  treated- 
cOVA  cOVA  cOVA  cOVA 
3DO-54.8  640  0  640  nt  0  320  nt 
3DO- 18.3  640  0  nt  640  0  nt  320 
Conditions of assay and glutaraldehyde fixation of presenter cells as described  in the Materials and 
Methods. Data presented is averaged from numerous assays. Variance of IL-2 responses are + one 
twofold dilution except for negative responses which were never positive. 
nt, not tested. 
FIGURE  1.  Failure of fixed A20-2J cells to catabolize cOVA. Fixed and unfixed A20-2J cells 
were incubated for 24 h with 125I-labeled  denatured cOVA and the cell-associated radiolabeled 
~2eptides analyzed by SDS-PAGE as described  in the Materials and Methods.  Lane 1, intact 
5I-cOVA (250,000 cpm). Lane 2, 12~I-cOVA  associated with unfixed A20-2J (100,000 cpm). 
125  Lane 3,  I-cOVA associated with fixed A20-2J (40,000 cpm). 
125I-labeled denatured cOVA and then washed to remove unbound antigen. Of 
the  input  radioactivity,  --~17%  remained  associated  with  the  unfixed  A20-2J 
cells, and 4% with the fixed A20-2J cells. The cell pellets were dissolved in SDS 
and the  lysates and  intact  l~SI-denatured cOVA  were  analyzed by  SDS-PAGE SHIMONKEVITZ  ET  AL.  313 
(Fig.  1). A  considerable portion of the cOVA associated with the unfixed A20- 
2J cells was degraded to 125I-labeled peptides ranging in molecular weight from 
"~20  to  35  kdaltons.  There  was  no  evidence  of degradation  of the  cOVA 
associated with the fixed A20-2J cells. 
Taken together these results strengthen our overall conclusion that metaboli- 
cally inert fixed cells cannot process antigen but are very effective at presenting 
preprocessed antigenic peptides. 
Discussion 
Recognition of protein antigens in vitro by I-region restricted, antigen-specific 
T  cells has been known for several years to require presentation of the antigen 
on an Ia-bearing cell. Although originally macrophages were thought to be the 
primary presenting cell (20, 30), there now exists convincing evidence that other 
cell types, especially B cells, can take up antigen effectively and present it in an 
I-region restricted fashion (24, 31). 
Observations, such as the lag time between antigen uptake and antigen pres- 
entation (15,  16), the equal effectiveness of native, denatured, and fragmented 
antigen  in stimulating secondary T  cell responses (10-14),  and the inhibitory 
effect of fixatives given before but not after incubation of the presenting cell 
with antigen (17,  26) have all led to the concept of antigen "processing." This 
term  has  commonly been  used  to  signify  the  uptake,  internalization,  partial 
degradation and/or modification, and re-expression on the cell surface of frag- 
ments of protein antigens that can be seen in association with I-region molecules 
by T  cells. 
Although the circumstantial evidence in favor of antigen processing is strong, 
there is little direct evidence for any of the steps involved. A  major obstacle in 
attacking this problem experimentally has been the inability to follow or control 
the  processing  of antigen  in  viable  presenting  cells.  Thus,  one  is  unable  to 
distinguish which of the catabolic pathways followed by the antigen are essential 
to antigen presentation and which are not. 
The experimental  system that  we developed to study this problem was  the 
stimulation of IL-2 production from a set of cOVA-specific, Ia-restricted T  cell 
hybridomas by cOVA presented by the Ia  +, BALB/c B cell lymphoma, A20-2J. 
This system had a  number of advantages.  First, all of our previous experience 
with these T  cell hybridomas indicated that their response depended only on the 
recognition of cOVA plus I  a molecules with no requirement for mediators such 
as,  interleukin-l,  from the  presenting cell.  Thus we  felt we could isolate  the 
events necessary for antigen  presentation  from other events related  to T  cell 
activation. Second, our set of T  cells were clonal and selected to cover as many 
of the various determinants on cOVA as possible. We expected that the individual 
determinants of the OVA  molecule may be processed in different ways; thus, 
the  complexity  of  antigen  processing  observed  with  a  heterogenous  set  of 
responding T  cells  might become simpler at  the  clonal  level.  Third,  we  had 
shown that  B  cell  lymphomas, such as  A20-2J,  were  very efficient at antigen 
presentation in that when compared to normal macrophages these cells took up 
less antigen and degraded antigen  less, but were equally or  more effective in 
antigen presentation. Thus, we felt that distinguishing essential from nonessential 314  CELL-FREE ANTIGEN PROCESSING 
antigen degradation might be easier in these cells. Finally, we took advantage of 
our recent observation that the antigen-presenting abilities of A20-2J and other 
types of presenting cells were not destroyed by fixation, provided that the cells 
were allowed sufficient time to process the antigen before fixation. We reasoned 
that the events essential to antigen processing might be definable outside the cell 
by using these presenting cells whose own metabolic capabilities were neutralized 
by fixation. 
The essential finding of our studies presented here was that A20-2J cells fixed 
with glutaraldehyde were unable to present cOVA unless the molecule had been 
previously  fragmented  either  chemically or  enzymatically.  As  expected,  the 
different fragmentation methods were more or less effective depending on the 
responding  T  cell  hybridoma  clone,  indicating  the  recognition of particular 
regions of the OVA molecule by individual T  cell hybridomas. These results 
offer direct evidence that antigen fragmentation is generally a required step in 
processing of the soluble protein antigen such as cOVA. 
Our results also led us to the unexpected conclusion that for this experimental 
system, antigen fragmentation was sufficient to define antigen processing since 
once degraded to peptides the antigen could be presented by apparently meta- 
bolically inert Ia  + cells. The strength of this conclusion was dependent on the 
effectiveness of the glutaraidehyde fixation of A20-2J.  Our experiments dem- 
onstrated that  these fixed cells were (a) not viable,  (b)  unable to  functionally 
process or biochemically degrade cOVA, (c) unable to synthesize protein, and (d) 
stable in their presenting function upon long term storage. These results certainly 
place  limitations  on  what  further  modifications the  fixed A20-2J  cells might 
make on  the  cOVA  peptide  fragments.  Nevertheless,  the fixation  conditions 
used in our experiments were quite mild and we cannot as yet rule out formally 
the possibility  that  some  cellular  functions (e.g.  surface membrane enzymes) 
survived the fixation and storage to play an essential role in the further modifi- 
cation of the antigen peptides. 
In  summary, the data  presented here confirms the central role  of antigen 
degradation in antigen processing for presentation to T  cells. This experimental 
system offers great promise in both investigating the essential steps in antigen 
processing and defining the nature of the antigen as it is recognized in association 
with I-region molecules by T  cells. 
Summary 
We examined the ability of a set of cloned chicken ovaibumin (cOVA)-specific, 
Id-restricted, T  cell hybridomas to produce interleukin-2 in response to cOVA 
presented by the Ia  + B cell iymphoma line, A20-2J. Although viable A20-2J cells 
presented native, denatured, and fragmented cOVA more or less equally well, 
A20-2J cells that were glutaraldehyde-fixed could present only enzymatically or 
chemically fragmented cOVA. These results suggest that antigen fragmentation 
may be both necessary and sufficient to define accessory cell processing of soluble 
antigens so that they may be recognized in association with I-region molecules 
by T  cells. 
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Sonia Colon for the preparation of the enzyme and chemical digests of ovalbumin, and 
Edna Squillante for the preparation of the manuscript. 
Received for publication 29 March 1983. 
References 
1.  M611er, G., editor.  1978.  Role of macrophages in the immune response. Immunol. 
Rev. 40:1. 
2.  Unanue, E., and A. Rosenthal, editors. 1980. Macrophage Regulation of Immunity. 
Academic Press, New York. 
3.  Unanue, E.  1981. The regulatory role of the macrophage in antigenic stimulation. 
II.  Symbiotic relationship between  lymphocytes and  macrophages. Adv.  Immunol. 
31:1. 
4.  Hodes, R., G. Ahmann, K. Hathcock, H. Dickler, and A. Singer. 1978. Cellular and 
genetic control of antibody responses  in  vitro.  IV.  Expression of Ia  antigens  on 
accessory cells  is  required for responses to soluble antigens  including a  response 
under Ir gene control. J. Immunol.  121 : 1501. 
5.  Cowing, C., S. Pincus, D. Sachs, and H. Dickler. 1978. A subpopulation of adherent 
accessory cells  bearing both  I-A and  I-E or C  subregion antigens  is required for 
antigen-specific murine T  lymphocyte proliferation.  J. Immunol.  121:1680. 
6.  Rosenthal,  A.  1978.  Determinant  selection and  macrophage  function  in  genetic 
control of the immune response. Immunol.  Rev. 40:136. 
7.  Berzofsky,  J., L. Richman, and D. Killian.  1979. Distinct H-2-1inked  Ir genes control 
both antibody and T  cell responses to different determinants on the same antigen, 
myoglobin. Proc. Natl. Acad. Sci.  USA.  76:4046. 
8.  Clark, R.,J. Chiba, S. Szweig, and E. Shevach. 1982. T cell colonies recognize antigen 
in association with specific epitopes on Ia molecules. Nature (Lond.) 295:412. 
9.  Hedrick, S.,  L.  Matis,  T.  Hecht, L.  Samelson,  D.  Longo, E.  Heber-Katz, and  R. 
Schwartz. 1982. The fine specificity of antigen and Ia determinant recognition by T 
cell hybridoma clones specific for pigeon cytochrome c. Cell.  30:141. 
10.  Ishizaka, K., H. Okudaira, and T. King. 1975. Immunogenic properties of modified 
antigen E. II. Ability of urea-denatured antigen and a-poly-peptide chain to prime T 
cells specific for antigen E.J. Immunol.  114:110. 
11.  Chesnut, R., R. Endres, and H. Grey. 1980. Antigen recognition by T  cells and B 
cells: recognition of cross-reactivity between native and denatured forms of globular 
antigens. Clin. Immunol. Immunopathol.  15:397. 
12.  Thomas, D., J. Schauster, and G. Wilner. 1981. Nature of T  lymphocyte recognition 
of macrophage-associated antigens. III. Definition of the antigenic regions of human 
fibrinopeptide B involved in guinea pig T  cell responses. Cell. Immunol.  58:238. 
13.  Thomas, J., W. Danho, E. Bullesbach,J. F6hlesand, and A. Rosenthal. 1981. Immune 
response gene control of determinant selection. III. Polypeptide fragments of insulin 
are differentially recognized by T  but not B cells in insulin-immune guinea pigs. J. 
Immunol.  126:1095. 
14.  Matis, L., S. Hedrick, C. Hannum, M. Ultee, D. Lebwohl, E. Margoliash, A. Solinger, 
E. Lerner, and R. Schwartz. 1982. The T  lymphocyte response to cytochrome c. III. 
Relationship  of the  fine specificity of antigen  recognition to  MHC  genotype. J. 
lmmunol.  128:2439. 
15.  Waldron, J.,  R.  Horn, and A.  Rosenthal.  1974.  Antigen-induced proliferation of 
guinea pig lymphocytes in  vitro:  functional aspects of antigen handling by macro- 
phages.J. Immunol.  112:746. 316  CELL-FREE ANTIGEN  PROCESSING 
16.  Calderon, J., and E. Unanue.  1974.  The release of antigen molecules from macro- 
phages: characterization of the phenomenon. J. Immunol.  112:1804. 
17.  Ziegler, K., and E. Unanue. 1981. Identification of a macrophage antigen-processing 
event required  for  I-region-restricted antigen presentation  to  T  lymphocytes. J. 
Immunol.  127:1869. 
18.  Ziegler, K., and E. Unanue. 1982. Decrease in macrophage antigen catabolism caused 
by ammonia and chloroquine is associated with inhibition of antigen presentation to 
T cells. Proc. Natl.  Acad. Sci. USA. 79:175. 
19.  Rhodes, M., P. Azari, and R. Feeney. 1958. Analysis, fractionation, and purification 
of egg white proteins with cellulose cation exchanger. J. Biol. Chem. 230:399. 
20.  Feeney,  R.,  and  R.  Allison.  1969.  Chicken  egg  white  proteins.  In  Evolutionary 
Biochemistry of Proteins. Wiley Intersciences, New York. 
21.  Colowick, S., and N. Kaplan. editors. 1967.  Enzyme structure. Methods Enzymol. Vol. 
11. 
22.  Mole,  L., S. Jackson,  R.  Porter,  and J.  Wilkinson.  1971.  Ailotypically related se- 
quences in the Fd fragment of rabbit IgH chains. Biochem. J.  124:301. 
23.  Kappler, J., B. Skidmore, J. White, and P.  Marrack.  1981.  Antigen-inducible, H-2- 
restricted, Interleukin 2-producing T cell hybridomas. Lack of independent antigen 
and H-2 recognition.J. Exp. Med.  153:1198. 
24.  Walker, E.,  N.  Warner,  R. Chesnut, J.  Kappler, and P.  Marrack.  1982.  Antigen- 
specific,  I region-restricted interactions in vitro between tumor cell lines and T  cell 
hybridomas.  J. Immunol.  128:2164. 
25.  Chesnut,  R.,  S.  Colon, and  H.  Grey.  1982.  Requirements for the processing of 
antigen by antigen-presenting B cells. I. Functional comparison of B cell tumors and 
macrophages.J. Immunol.  129:2382. 
26.  Chesnut, R., S. Colon, and H. Grey. 1982.  Antigen presentation by normal B cells, 
B cell tumors and macrophages: functional and biochemical comparison. J. Immunol. 
128:1764. 
27.  Laemmli, U.  1970.  Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature (Lond.). 227:680. 
28.  Bubbers, J., and C. Henney. 1975.  Studies on the synthetic capacity and antigenic 
expression of glutaraldehyde-fixed target cells. J. Immunol.  114:1126. 
29.  Mosier, D.  1967.  A requirement for two cell types for antibody formation in vitro. 
Science (Wash. DC). 159:1573. 
30.  Rosenthal, A., and E. Shevach. 1973. Function of macrophages in antigen recognition 
by guinea pig T  lymphocytes. I. Requirement for histocompatible macrophages and 
lymphocytes.J. Exp. Med.  138:1194. 
31.  Grey,  H.,  S.  Colon, and  R.  Chesnut.  1982.  Requirements for the  processing of 
antigen by antigen-presenting B cells.  II.  Biochemical comparison of the rate of 
antigen in B cell tumors and macrophages.J. Immunol.  129:2389. 